These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 12447866

  • 1. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.
    Chu CJ, Hussain M, Lok AS.
    Hepatology; 2002 Dec; 36(6):1408-15. PubMed ID: 12447866
    [Abstract] [Full Text] [Related]

  • 2. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 3. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [Abstract] [Full Text] [Related]

  • 4. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T.
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S.
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [Abstract] [Full Text] [Related]

  • 11. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M, Zhou X, Wei L, Qiu S, Zhou T, Li L, Gu X, Luo M, Zheng X.
    Virol J; 2007 Sep 24; 4():93. PubMed ID: 17892580
    [Abstract] [Full Text] [Related]

  • 13. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S.
    Gastroenterology; 2008 May 24; 134(5):1376-84. PubMed ID: 18471514
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug 24; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 15. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov 24; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 16. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA.
    Ned Tijdschr Geneeskd; 2008 Jun 21; 152(25):1426-30. PubMed ID: 18624006
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.
    Gut; 2008 Apr 21; 57(4):500-6. PubMed ID: 18025069
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Med Virol; 2004 Mar 21; 72(3):363-9. PubMed ID: 14748059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.